StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Looking forward to the conference call

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Mar 29, 2021 12:13am

201 Views

Post# 32896478

RE:Looking forward to the conference call

Nasdaq would also clean up any shorts or naked shorts with a cusip change.

Nailbiter1 wrote: For once I would like to see an after-trading conference call.
I have a strong feeling these next two earnings reports will be head-turners requiring
more than the 30-45 minutes James gives us before the markets open in the morning.
Many new revelations will bring many questions from retail and institutional investors.
These two quarters could bring us very close to the Nasdaq threshold and if we cross through, we will be in full view of those huge hungry American investors.
Monday...
Tuesday...